Key result
Management of patients with a systemic right ventricle, such as those with D-TGA or CCTGA, remains a unique challenge in the growing population of adults with congenital heart disease.
Highlights the ongoing challenges in managing implantable defibrillators in adults with congenital heart disease and a systemic right ventricle.
The prevalence of congenital heart disease (CHD) has remained relatively stable in newborns over the past several decades. With improvements in cardiac management, there are now more adults with CHD (ACHD) than children in most of the developed world.1 A unique challenge that remains is the management of a patient with a systemic right ventricle (sRV). Two prevalent conditions are D-transposition of the great arteries (D-TGA) repaired with an atrial baffle procedure and congenitally corrected transposition of the great arteries (CCTGA).
No takes yet. Share an insight, caveat, or question.
Vijayashankar et al. (2025) conducted an editorial in Congenital heart disease with a systemic right ventricle. Implantable Defibrillator was evaluated. Management of patients with a systemic right ventricle, such as those with D-TGA or CCTGA, remains a unique challenge in the growing population of adults with congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: